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Abstract 
Purpose: To evaluate the in vitro antioxidant and anti-neuroinflammatory activities of Hizikia fusiformis 
(Harvey) Okamura extract (HFE) in lipopolysaccharide (LPS)-stimulated murine BV-2 microglial cells. 
Methods: The antioxidant activity of HFE was evaluated by measuring 1, 1-diphenyl-2-picryl-hydrazyl 
(DPPH) radical-scavenging activity using an ESR spectrometer. Cell viability was estimated by 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT) assay. LPS-stimulated BV-2 microglia 
were used to study the expression and production of inflammatory mediators such as nitric oxide (NO), 
inducible NO synthase (iNOS) and Interleukin 6 (IL-6).  
Results: Treatment with Hizikia fusiformis extract (HFE) significantly scavenged the DPPH radicals with 
half-maximal concentration of (IC50) of 9.64 ± 0.78 μg/ml (p < 0.01 at 10 μg/ml). The increased levels of 
NO (35.32 ± 3.62 μM) and protein expressions of iNOS were inhibited by HFE extract in LPS-stimulated 
BV-2 cells. Increased pro-inflammatory cytokines such as TNF-α and IL-6, were also significantly 
suppressed by HFE (p < 0.001 at 80 μg/ml). Further, HFE blocked the expression of NF-κB activation in 
LPS-stimulated BV-2 cells.  
Conclusion: HFE can be considered as a useful therapeutic and preventive approach for the treatment 
of neurodegenerative diseases and oxidative stress-related diseases. 
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Hizikia fusiforme is important economic brown 
seaweed, used as a healthy foodstuff, medical 
herb and marine vegetable in Korea, Japan, and 
China [1]. Recent evidence suggests that H. 
fusiforme contains a number of compounds 
possessing anti-oxidant, anti-inflammatory, and 
anticoagulant proprieties [2]. Karawita et al [3] 
has reported that H. fusiforme has a variety of 
physiological activites.  However, the beneficial 
effect of Hizikia fusiforme on neuroinflammation 
in activated microglial cells has not been studied.  
 
Microglia are the resident macrophage-like cells 
of the central nervous system (CNS) with a broad 
role in the innate immunity and in inflammatory 
neuro pathologies [4]. They are highly responsive 
to stress and injury and become immediately and 
focally activated in response to Alzheimer’s 
disease (AD), Parkinson’s disease (PD), multiple 
sclerosis (MS), and amyotrophic lateral sclerosis 
(ALS) [5,6]. Also, microglia are involved in 
initiating inflammatory responses in the brain 
through secreting a variety of inflammatory 
mediators, including nitric oxide (NO), inducible 
Lee & Kang 
Trop J Pharm Res, March 2015; 14(3): 464  
 
NO synthase (iNOS) and interleukins (IL). Thus, 
modulation of activated microglia is an effective 
strategy for therapeutics in neuro inflammation. 
 
The most common cause of inflammatory 
responses is exposure to lipopolysaccharide 
(LPS), a component of the outer membrane of 
Gram-negative bacteria [8]. LPS-activation of 
BV-2 microglia cells results in a wide range of 
responses, including secretion of pro-
inflammatory mediators. Therefore, suppression 
of aberrant activation of BV-2 microglia cells may 
have valuable therapeutic potential for the 
treatment of inflammatory diseases such as AD 
and PD [9].  
 
In this study, we investigated the effects of H. 
fusiforme on NO production, expression of iNOS, 
and pro-inflammatory cytokines from LPS-
stimulated BV-2 microglia cells. The findings 
demonstrate that H. fusiforme may be used as a 
source of drug candidate for the prevention or 




Preparation of Hizikia fusiforme extract (HFE) 
 
Hizikia fusiforme was washed with running tap 
water, dried at 60 °C for 24 h and then ground to 
fine powder. Each powder was extracted with 10 
volumes (v/w) of 70 % ethanol at a room 
temperature for 72 h and filtrated. The filtered 
extract was concentrated by a rotary evaporator 
(EYELA NVC-2000, Tokyo, Japan) under 
reduced pressure and lyophilized. 
 
DPPH radical scavenging activity  
 
This assay was based on the scavenging of 
stable 2, 2-diphenyl-1-picrylhydrazyl (DPPH, 
Sigma-Aldrich, St. Louis, MO, USA) radicals by 
the radical scavenging antioxidants in HFE. The 
radical scavenging capacity was evaluated by 
employing a reaction mixture constituted by 
aliquots of the HFE and a DPPH methanolic 
solution as described previously [10]. A sample 
solution of 60 µL of each Hizikia fusiformis 
extract, was added to 60 µL of DPPH (60 µM) in 
methanol. After mixing vigorously for 10 s, the 
mixture was then transferred into a 100 µL Teflon 
capillary tube and the scavenging activity of each 
sample on DPPH radical was measured using a 
JES-FA ESR spectrometer (Jeol Ltd., Tokyo, 
Japan). A spin adduct was measured on an ESR 
spectrometer exactly after 2 min. Experimental 
conditions were as follows: central field, 3,475 G; 
modulation frequency, 100 kHz; modulation 
amplitude, 2 G; microwave power, 5 mW; gain, 
6.3 x 105, and temperature, 298 °K. 
 
Cell cultures and viabilities 
 
BV-2 microglia cells were grown in RPMI1640 
(Invitrogen, Carlsbad, CA, USA), supplemented 
with 10 % FBS (Hyclone, Logan, UT, USA)  
containing 100 U/mL of penicillin (Invitrogen), 
and 100 μg/mL streptomycin (Invitrogen)  at 37 
°C in humidified atmosphere of 5 % CO2. In all 
experiments, cells were pre-treated with the 
indicated concentrations of HFE for 1 h before 
the addition of LPS (1 µg/mL, Sigma-Aldrich, St. 
Louis, MO, USA) in serum- free RPMI1640. An 
equal volume of sterile water was added to all 
control treatments. Cell viability was determined 
by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) assay as 
described previously [11]. Cells were incubated 
with various concentrations of HFE for 24 h 
followed by MTT for 4 h, and then 100 μL of 
isopropanol (in 0.04 N-hydrochloric acid) was 
added to dissolve the formazan crystals. The 
absorbance was read at 570 nm using the 
spectrophotometer (Tecan, USA). Cell viability 
was calculated as relative absorbance compared 
to control. 
 
Nitric oxide assay 
 
The amount of NO production in the medium was 
detected with the Griess reaction [12]. Each 
supernatant was mixed with the same volume of 
Griess reagent (1 % sulfanilamide in 5 % 
phosphoric acid and 0.1 % naphthyl 
ethylenediamine dihydrochloride in water). The 
absorbance of the mixture at 540 nm was 
determined with an ELISA reader (Bio-Tek 
Instrument, Winooski, VT, USA). Nitrite 
concentration was determined from a sodium 




BV-2 cells were lysed in a buffer containing 20 
mM Tris‐HCl (pH 7.5), 150 mM NaCl, 1 mM 
EDTA, 50 mM β‐glycerophosphate, 1 % NP‐40, 
1 mM Na3VO4 and 1 X protease inhibitor cocktail 
(Complete MiniTM, Roche, Mannheim, 
Germany). The lysates were centrifuged at 
15,000 X g for 15 min and supernatants were 
collected. The concentrations of protein samples 
were measured using the BCA reagent (Pierce, 
Rockford, IL, USA). The protein was separated 
by sodium dodecylsulphate (SDS) 
polyacrylamide gel electrophoresis (PAGE) and 
transferred to PVDF membranes. After blocking 
with 5 % non‐fat milk, the membranes were 
hybridized with 1:1000 dilutions of primary 
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antibodies for iNOS and β-actin for 12 h at 4 °C. 
Membranes were washed with Tris‐buffered 
saline containing 0.1 % Tween‐20 (TBST) three 
times at 5 min-interval and hybridized with 
horseradish peroxidase‐conjugated mouse or 
rabbit secondary antibodies for 1 h at room 
temperature. After washing three times with 
TBST, antigen‐antibody complexes were 
visualized with an ECL Western Blot Detection 
Kit (GE Healthcare) according to the 
manufacturer’s instructions. The antibodies 
against iNOS and β-actin were purchased from 





BV-2 microglia cells (1 x 105 cells/well) were 
cultured on 96 well plates and treated with the 
HFE at indicated concentrations for 1 h  and 
stimulated with LPS (1 µg/ml). At 24 h post LPS 
treatment, the production of IL-6 was determined 
in cell supernatant using assay kits (BD 
Biosciences, San Jose, CA, USA) as per the 
manufacturer’s instructions. The IL-6 assay was 
performed at room temperature and optical 





All data are presented as mean ± S.E.M (at least 
n = 3). Statistical analyses were performed using 
SAS statistical software (SAS Institute, Cray, NC, 
USA) using one-way analysis of variance, 
followed by Dunnett's multiple range tests. P < 




Effect of HFE on DPPH radical scavenging 
activity 
 
As shown in Fig 1A, HFE exhibited significant 
DPPH radical scavenging activity in a dose-
dependent manner showing a maximum effect at 
1 mg/mlL. ESR spectroscopy data at 0.1, 1, 10, 
100 and 1000 µg/mL are represented in Fig 1B. 
 
Effect of HFE on LPS-induced NO production 
 
HFE treatment did not exhibit any significant 
cytotoxicity in BV-2 microglial cells treated for 24 
h at concentrations up to 200 µg/mL, and in all 
cases the viability was found above 96 % by 
MTT assay (Fig 2).  As shown in Fig. 3, 
treatment of LPS resulted in excessive 
production of NO. Pretreatment of HFE 
significantly suppressed the LPS-induced NO 
production in a concentration-dependent manner 
(Fig 2). The maximum effect was seen at 100 




Fig 1: Effect of HFE on DPPH radical scavenging activity. The capacity to scavenge DPPH free radical by 
different concentrations HFE (A) and ESR spectra (B) was measured. BV-2 cells were treated with or without 
HFE at the various concentrations (0.1, 1, 10, 100, and 1000 μg/mL). The scavenging activity of each sample on 
DPPH radical was measured using a JES-FA ESR spectrometer. A spin adduct was measured on an ESR 
spectrometer exactly 2 min later. HFE: Hizikia fusiforme ethanol extract 
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Fig 2: Effect of HFE on the viability of BV-2 microglial cells. Viability in HFE treated cells was determined using 
MTT assay. The results are displayed in percentage of control samples. Data are presented as the mean ± 




Fig. 3: Effect of HFE on NO Production in LPS-stimulated BV-2 microglial cells. BV-2 cells were treated with HFE 
at various concentrations (10, 20, 80, and 100 µg/ml) with or without LPS (1 µg/ml) for 24 h. The nitrite in the 
culture supernatant was evaluated using Griess reagent. Data are presented as the mean ± S.E.M. (n=3) for 
three independent experiments. #p<0.001, when compared with control group. * p < 0.05, ** p < 0.01 and ***p < 
0.001, when compared with LPS alone treated group by one-way analysis of variance, followed by Dunnett's 
multiple range tests. HFE: Hizikia fusiforme ethanol extract 
 
Effect of HFE on LPS-induced expressional 
levels of iNOS 
 
LPS strongly induced BV-2 cells to produce an 
increased expression of iNOS. However, 
treatment with HFE exhibited a broad spectrum 
of inhibitory effect on the expression of iNOS 
induced by LPS in BV-2 cells (Fig 4). 
 
Effect of HFE on IL-6 production in LPS-
stimulated BV-2 cells  
 
To determine the effect of HFE on the expression 
of pro-inflammatory cytokines such as IL-6, 
extracellular release of cytokines was examined 
using ELISA assay. As shown in Fig 5, IL-6 
levels increased significantly after LPS treatment 
(1 µg/mL) when compared to those in untreated 
cells (p < 0.001). However, HFE significantly 
inhibited IL-6 production in a concentration-
dependent manner in LPS-stimulated BV-2 cells 





Fig 4: Effect of HFE on iNOS protein expressional 
levels in LPS-stimulated BV-2 microglial cells. The 
expression levels of iNOS production in the LPS-
stimulated BV-2 cells by indicated concentrations (50 
and 100 µg/ml) of the HFE was monitored by 
immunoblot analyses with the specific antibodies 
against iNOS. The internal control used was β-actin. 
HFE: Hizikia fusiforme ethanol extract; LPS= 
Lipopolysaccharide; iNOS: Inducible nitric oxide 
synthase 
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Fig 5: Effect of HFE on IL-6 production in LPS-stimulated BV-2 microglial cells. Suppression of pro-inflammatory 
cytokine IL-6 expression by HFE was measured with ELISA test. BV-2 cells were treated with HFE at 20, 40 and 
80 µg/mL with or without LPS (1 µg/ml) for 24 h. The IL-6 in the culture supernatant was evaluated using a 
murine IL-6 ELISA kit. Data are presented as the mean ± S.E.M. (n = 3) for three independent experiments. #p< 
0.001, when compared with control group. * p <0.05, and **p < 0.01, ***p < 0.001 when compared with LPS alone 




Hizikia fusiforme (HFE) is one of the major 
farmed alga species along the Korea, Japan and 
Chinese coast. The polysaccharides present in 
HFE have become the focus of intense interest 
due to their various bioactivities. HFE contains a 
number of compounds that exert anti-
inflammatory, anti-oxidant and anticoagulant 
proprieties [2]. It also contains inorganic arsenic, 
which is carcinogenic to humans [3]. A 
polysaccharide with protective effects against 
ethanol-induced peptic injury has been isolated 
from HFE [19]. The present study demonstrated 
that HFE possesses an anti-neuroinflammatory 
activity in LPS-stimulated BV-2 microglia cells 
and antioxidant activity. Further HFE exhibited 
significant antioxidant activity evaluated by 
DPPH free radical scavenging method. Free 
radicals and reactive oxygen species (ROS) are 
important causative factors in the development of 
age-related neuroinflammatory and 
neurodegenerative diseases [13]. Thus 
neutralization by antioxidants and radical 
scavengers can reduce neuroinflammation. It is 
well known that DPPH radical assay is one of the 
widely used methods for evaluating the free 
radical scavenging activities of several 
antioxidants in a relatively short period of time 
[14]. In our present study, the HFE also exhibited 
significant free radical scavenging effect 
indicating that the HFE might contain potential 
antioxidant agent. Since antioxidants reduce 
neuro inflammation [13]. 
  
We used HFE to evaluate for its anti-
neuroinflammatory activity in LPS-stimulated BV-
2 microglial cells. In BV-2 microglia cells, NO is 
generated by the inducible isoform of NO 
synthase (iNOS) and has been described as a 
neurotoxic substance in the processes of CNS 
inflammation [15]. Thus, high levels of NO are 
produced from L-arginine by iNOS in the brain by 
prolonged activation of microglial cells, and this 
response is associated with the progression of 
various neurodegenerative diseases [16]. Our 
results clearly showed that HFE attenuated LPS-
induced iNOS expression and downstream NO 
production. This indicates that HFE acts 
principally by regulating NO generation at the 
post-transcriptional level and could be beneficial 
for preventing the progression of neuro 
inflammation by BV-2 microglial activation.  
 
Pro-inflammatory cytokines such as IL-6 are the 
initiators of the inflammatory response and the 
mediators of the development of chronic 
inflammatory diseases [17]. Therefore, the over 
production of pro-inflammatory cytokines, by 
activated microglia cell is a possible etiological 
factor of neurological disorders [18].  Microglial 
cell activation by LPS produces various cytokines 
including IL-6 leading to the attraction of 
neutrophils and the accumulation of neutrophil-
secreted proteases and ROS at the site of 
inflammation. Data from our study showed that 
HFE may act by suppressing the increased 
production of IL-6 thereby inhibiting NO 
production and iNOS expression levels in LPS-
stimulated murine BV-2 cells indicating that HFE 
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The findings of this study demonstrate that HFE 
has anti-inflammatory properties in LPS-induced 
murine BV-2 microglial activation through the 
down-regulation of inflammation-related gene 
expression, including iNOS and pro inflammatory 
cytokine such as IL-6. The strong antioxidant 
effects exhibited by HFE may also be involved in 
delivering such actions. Therefore, HFE can be 
considered a useful therapeutic strategy for the 
natural treatment of neurological disorders and 
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